| Patent application number | Description | Published |
|---|
| 20100119223 | Optical Safety Implementation in Protection Switching Modules - Optical safety functions are incorporated into protection switching modules which maintain redundant pathways to avoid interruptions in optical network connections. The optical safety functions which lower optical power levels upon interruptions of optical connections are effectively combined with protection switching procedures which are also triggered by interruptions in optical network connections. The interoperation of protection and safety processes keep optical power levels below hazardous levels at system points which might be accessible to human operators. | 05-13-2010 |
| 20100284687 | All Optical 1+1 Protection Unit Using Sub-Carrier Modulation Protocol - An interface between a network component and an optical fiber section communicates with a remote interface and a remote network component at an opposite end of the optical fiber section through over-modulation of optical signals sent between the interfaces and network components. The over-modulation is at frequencies much lower than the ordinary modulation of the optical signals. The over-modulation allows communication between the interfaces for performing management, testing and maintenance operations and permits superior detection of faults in the optical fiber section. | 11-11-2010 |
| 20110268439 | Selecting an Optical Path for a New Connection with the Minimum Number of Optical Regenerators - Techniques are provided for receiving a connection request at a first network node configured to request a connection from the first network node to a second network node. At the first network node, it is determined if a path to the second network node without an optical regenerator is available for the connection. In response to determining that a path without an optical regenerator is not available, a path to the second network node is determined that has a minimum number of optical regenerators. The connection is set up using the path with the minimum number of optical regenerators. | 11-03-2011 |
| 20130129342 | Optical Safety Implementation in Protection Switching Modules - Optical safety functions are incorporated into protection switching modules which maintain redundant pathways to avoid interruptions in optical network connections. The optical safety functions which lower optical power levels upon interruptions of optical connections are effectively combined with protection switching procedures which are also triggered by interruptions in optical network connections. The interoperation of protection and safety processes keep optical power levels below hazardous levels at system points which might be accessible to human operators. | 05-23-2013 |
| Patent application number | Description | Published |
|---|
| 20080267952 | Antibodies to Cross-Linked Beta-Amyloid Protein Oligomers - The invention relates to antibodies that bind cross-linked amyloid β oligomers, and methods for using such antibodies for diagnosis and treatment of Alzheimer's disease. | 10-30-2008 |
| 20110200564 | DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE (AD) - Disclosed herein are novel methods, assays and systems for detecting an increased risk for Alzheimer's disease (AD) in a subject by identifying at least one nuclei acid polymorphism described herein in a biological sample from the subject. Levels of the genes associated with the nucleic acid polymorphism described herein are also determined for detection of higher risk for AD. Disclosed herein further provides methods for treating AD by administering to a subject in need thereof with ATXN1. | 08-18-2011 |
| 20120316247 | PREVENTION AND TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD) - Disclosed herein is a method for administering compositions. Also disclosed are kits comprising a compound of formula (I) to (V), or an enantiomer, an analog, a derivative, an isomer, prodrug, or a pharmaceutically acceptable salt thereof, for use in temporal proximity to anesthesia. The methods, compositions and kits provided herein can be used for reducing anesthesia-induced neurotoxicity and post-operative cognitive dysfunction (POCD) in a subject. | 12-13-2012 |
| Patent application number | Description | Published |
|---|
| 20100113570 | PREVENTION AND TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION - Methods for the use of uncompetitive NMDA receptor antagonist(s) in inhalational anesthesia are provided herein. | 05-06-2010 |
| 20100311726 | REDUCTION OF BETA-AMYLOID LEVELS BY TREATMENT WITH THE SMALL MOLECULE DIFFERENTIATION-INDUCING FACTOR - The present invention relates to novel uses for a family of small molecules, Differentiation-Inducing Factors (DIFs). It has been discovered that DIFs surprisingly can alter the metabolic processing of amyloid precursor protein (APP) and in turn reduce the level of secreted Aβ. The metabolic processing of other γ-secretase substrates normally present in cells (Notch and APLP1) is not affected when treated with DIF. The invention provides methods for reducing Aβ production in mammalian cells that express APP by administering DIF-I, DIF-2, DIF-3, a functionally equivalent analog and or any combination thereof. The invention also provides methods for treating and/or preventing Alzheimer's disease by preferentially reducing Aβ production. | 12-09-2010 |
| 20110177543 | REGULATION OF BACE DEGRADATION - The invention relates to methods and products for diagnosing, preventing, and treating Alzheimer's disease and abnormal production of amyloid β. | 07-21-2011 |
| 20120058935 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREFORE - The invention features antimicrobial compositions comprising β-amyloid peptides, oligomers, and analogs thereof, and methods of using them for the prevention or treatment of an infection. | 03-08-2012 |
| 20120114635 | ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS - The invention relates to antibodies that bind cross-linked amyloid β oligomers, and methods for using such antibodies for diagnosis and treatment of Alzheimer's disease. | 05-10-2012 |
| 20130022994 | REGULATION OF BACE DEGRADATION - The invention relates to methods and products for diagnosing, preventing, and treating Alzheimer's disease and abnormal production of amyloid β. | 01-24-2013 |
| 20140377267 | ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS - The invention relates to antibodies that bind cross-linked amyloid β oligomers, and methods for using such antibodies for diagnosis and treatment of Alzheimer's disease. | 12-25-2014 |
| 20150218259 | ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS - The invention relates to antibodies that bind cross-linked amyloid β oligomers, and methods for using such antibodies for diagnosis and treatment of Alzheimer's disease. | 08-06-2015 |
